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Platelet-derived growth factor (PDGF) has been assigned a
broad range of biological roles in contexts ranging from devel-
opment and oncogenesis to wound healing and atherogenesis
[1]. Originally assayed as mitogenic activity released from
platelets, it is now appreciated that, in addition to its prolifer-
ative actions, PDGF stimulates other processes including
chemoattraction, deposition of extracellular matrix and neu-
ronotropism. All these biological activies are mediated through
transmembrane cell surface tyrosine kinase receptors.
One or more of three dimeric PDGF isoforms (PDGF AA,
AB, and BB) are expressed by several cell types within the
kidney, including resident endothelial, mesangial, vascular
smooth muscle and interstitial cells, as well as immigrant
mononuclear cells. Recent demonstration that PDGF and
PDGF receptor expression are increased at vascular and gb-
merular sites in renal allograft rejection and in animal models of
renal disease has supported a role for PDGF in the pathogenesis
of destructive proliferation and inflammation [2, 3].
The biological activities of individual PDGF isoforms depend
upon their high affinity binding to cell surface receptors expressed
on responsive cells. Two molecularly distinct, but highly homol-
ogous receptors for PDGF molecules, PDGF a and /3 receptors,
were initially distinguished by isoform binding specificities, and
subsequently by cDNA cloning, as distinct peptides sharing struc-
tural and functional characteristics. Individual cell types may
express one or both forms of PDGF receptor [4]. Responses to
distinct PDGF isoforms are mediated through receptor dimers
which may apparently contain one or both receptor types (Heldin,
this issue). The functional studies of PDGF receptor coupling
reviewed here refer largely to PDGF /3 type receptor responses to
PDGF BB in murine fibroblasts. It is likely that discrete mecha-
nisms coupling PDGF /3 receptors to intracellular effector en-
zymes reflect processes shared among other cell types, including
mesangial and fibroblast-like cells of the kidney. The molecular
basis for distinct responses to individual PDGF isoforms in cell
types expressing both a and /3 receptors remain to be resolved.
PDGF receptors: Structure and function
Structural features of PDGF a and /3 receptors contribute to
our current understanding of how these molecules transduce
extracellular ligand binding events into intracellular biochemi-
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cal signals. Both a and /3 receptor types are membrane spanning
glycoproteins having extracellular immunoglobulin-like do-
mains which participate in ligand binding, a single membrane
spanning domain, and an intracellular tyrosine kinase domain
homologous to the functional kinase domain of the c-src pro-
tooncogene and its related non-receptor tyrosine kinases [5].
This kinase domain is interrupted in both PDGF a and /3
receptors by an "insert" domain, the presence of which defines
a subclass of tyrosine kinase receptors including the c-fms
protein receptor for CSF-l and the receptor for fibroblast
growth factor, as indicated in Figure 1.
Binding of PDGF to extracellular receptor domains initiates a
progression of events through which PDGF receptors interact
with several distinct signaling proteins. Ligand binding appears to
induce dimerization of individual receptor molecules, and is
tightly coupled to receptor tyrosine seIf-phosphorylation [6]. In
fact, data suggest receptor dimerization is initiated by a or /3 type
PDGF receptor monomers binding the individual PDGF isoforms
for which they have highest affinity (Heldin, this issue).
PDGF receptor tyrosine seif-phosphorylation
One of the earliest events initiated by PDGF binding to the
receptors' extracellular domain is tyrosine self-phosphorylation
of two intracellular domain sites (tyrosine residues 751 and 857)
[7]. This self-phosphorylation is mediated by tyrosine kinase
activity intrinsic to the receptor. Data from other tyrosine
kinase receptors (c-fms, EGF receptor) suggest that self-phos-
phorylation of one receptor monomer is catalyzed by the
activity of the other monomer's kinase within the dimer pair [81.
If PDGF receptor functions similarly, the importance of ligand-
induced dimerization in receptor self-phosphorylation is evi-
dent, At present, self-phosphorylated PDGF receptors appear
to represent the active receptor form which has optimal ty-
rosine kinase activity on exogenous substrates and interacts
with the downstream effector enzymes indicated in Figure 2.
Several observations suggest PDGF receptor tyrosine self-
phosphorylation may function as a switch, conferring potential
for interaction with other proteins which participate in PDGF-
coupled responses. Tyrosine phosphorylated PDGF receptors
have accessible for antibody recognition a cytoplasmic domain
epitope which is cryptic in unactivated, non-phosphorylated
PDGF receptors [9]. Moreover, self-phosphorylated PDGF
receptors stably associate in coprecipitable complexes with
effector enzymes such as phospholipase C (PLC), as discussed
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Fig. 1. PDGF receptor a and f3 types are
members of a subclass of tyrosine kinase
receptors having an intracellular tyrosine
kinase domain interrupted by a peptide
'insert" which is distinct among these
proteins. Abbreviations are: PDGF receptors
(PDGF R); EGF receptor (EGF R); Insulin
receptor (Ins R); CSF-1 receptor (CSF-1 R);
fibroblast growth factor receptor (FGF R).
Symbols are: () cysteine rich; (.) cysteine;
() C-src homologous tyrosine kinase.
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below. Finally, receptor dephosphorylation disrupts its capac-
ity for stable association with PLC [10].
PDGF receptor coupled effector enzymes share structural
determinants
Efforts of several laboratories have defined participants in
PDGF receptor signaling. Several PDGF receptor-coupled sig-
nal-generating enzymes have been identified by recognition that
they undergo tyrosine phosphorylation in response to PDGF
stimulation of intact cells [11—14]. These include phospholipase
C7 (PLC), the ras GTPase activating protein (GAP), and the 85
kDa subunit of an enzyme containing phosphatidyl-inositol
Fig. 2. Intracellular effecior enyzmes coupled
to PDGF receptor activation. Abbreviations
are: PLC (phospholipase C,,); c-ras GTPase
activator protein (GAP); phosphatidylinositol-
3-kinase (85 kDa subunit) (P13 K); cellular
homologue of the v-raf serine kinase (c-raf);
diacylglycerol (DAG); inositol-
(1 ,4,5)trisphosphate (InsP,).
3-kinase (P13K) activity. As one member of a family of PLC
isoenzymes with similar activity, PLC7 is implicated in produc-
tion of second messengers, inositol-(l,4,5)-trisphosphate
(InsP3) and diacylglycerol (DAG), which signal downstream
calcium release and kinase C activation, respectively [15]. GAP
has been implicated as a major participant in proliferative
responses signaled through the cellular homologue of the v-ras
oncogene [16]. To date, a clear role for the 3-phosphorylated
phosphatidylinositol products of the P13K remains to be eluci-
dated, however, analysis of the function of mutated PDGF f3
receptors has suggested that P13K activation may correlate best
with PDGF-induced mitogenic responses [12, 17].
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Fig. 3. SH2 and SH3 domains homologous to
P13K non-kinase regions of c-src: Components of
(85k) PDGF receptor-coupled effector enzymes.
Abbreviations are: Phospholipase C (PLC);
c-ras GTPase activator protein (GAP);
phosphatidylinositol-3-kinase- (85 kDav-cr
subunit) (P13K).
Relevant to the previous suggestion that tyrosine phos-
phoproteins participate in stable protein-protein associations, it
has been recognized that PDGF-induced tyrosine self-phos-
phorylation of PDGF receptors promotes their formation of
coprecipitable complexes with each of the effector enzymes
which undergo tyrosine phosphorylation (Fig. 2). As the pri-
mary amino acid sequences for PLC7, GAP, and P13K (85 kDa
subunit) have been defined by cDNA sequence, additional
support for some functional importance for their stable associ-
ation with tyrosine phosphorylated PDGF receptors has been
generated.
PLC7, GAP and P13K share domains which are homologous
to regions of the nonreceptor tyrosine kinases of the c-src
family termed SH2 and SH3 domains [18]. First appreciated to
determine host range susceptibility for v-src transformation and
to be the site of mutations in temperature-sensitive transform-
ing mutant versions of v-src, additional interest in these non-
kinase domains of the src kinase family was generated with
cloning of the transforming oncogene of the CT1O retrovirus,
v-crk. This molecule includes SH2 and SH3 domains, and
appears to activate native cellular tyrosine kinases in effecting
its transforming function [19]. The v-crk protein associates
stably with tyrosine phosphoproteins, as do the bacterially-
expressed SH2 domains of PLC7 and GAP.
Proteins having SH3 domains appear to share capacity for
interaction with cytoskeletal elements, and elements of the SH3
domain have been implicated in the association of c-src with the
plasma membrane. Given the focal concentration of cellular
tyrosine phosphoproteins at focal contact sites, it may not be
surprising that SH2 and SH3 domains have been identified in
several proteins which have the capacity for membrane associ-
ation and additional proteins which participate in cytoskeletal
interactions. Included among these SH3 domain containing
proteins are fodrin, myosin ib, a yeast actin binding protein,
neutrophil NADPH-oxidase-associated proteins, and c-crk (the
cellular homologue of the transforming gene product). Most
recently, an actin binding protein, tensin, has been shown to
have an intrinsic SH2 domain and to be a substrate for tyrosine
kinase activity [20].
The early localization of tyrosine phosphoproteins to focal
contacts which serve to anchor cytoskeletal elements at points
of attachment either between cells or with subcellular matrix
between cultured cells provided some indication that tyrosine
phosphoproteins may participate in stable protein-protein asso-
ciations required for cytoskeletal integrity. These dense recog-
nizable structures contain several cytoskeletal proteins includ-
ing vinculin and talin, both of which have been shown to be
tyrosine phosphoproteins.
In summary, the function apparently implicit to SH2 domains
represented in these diverse proteins is the capacity to form
stable interactions with tyrosine phosphoproteins, including
seif-phosphorylated tyrosine kinases such as PDGF receptor.
SH3 domains appear to be shared among proteins which are
either recruited to tight association with the plasma membrane,
or to proteins such as fodrin which are crucial elements of the
cytoskeleton.
PDGF receptor-phospholipase C coupling: Role of protein-
protein association
Although several effector enzymes are coupled to PDGF
receptor activation, certain experimental advantages are real-
ized in addressing the coupling of phospholipase C to PDGF
receptor function. PDGF stimulated, PLC-mediated production
of InsP3 is easily assayable in intact cells, as it is released from
metabolically prelabéled phosphatidylinositol stores. In addi-
tion, in vitro assays for inositol phospholipid specific phospho-
lipase C activity may be used to assay PLC activity recovered
by phosphotyrosine antibodies or through coprecipitation with
PDGF receptors. We have used these advantages to explore the
role played by formation of a complex between PDGF receptors
and PLC7 in mediating productive PLC7 activation. Despite
this, current understanding emphasizes that several of the
parallel effector systems indicated in Figure 3 participate in the
mitogenic responsiveness.
Only two methods are currently available for marking cellular
PLC molecules as having interacted with PDGF receptors. The
PLC protein and activity may be assayed following recovery by
phosphotyrosine antibodies from PDGF stimulated cells. Sim-
ilarly, coprecipitation of PLC activity and protein with anti-
body-recovered PDGF receptors allows identification of the
subpopulation of PLC complexed with PDGF receptors under
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Fig. 4. Functional consequences of PDGF association/dissociationireassociation at 4°C on PDGF receptor tyrosine phosphorylation, integrity of
receptor-PLC7 coprecipirable complex, and subsequent PDGF-coupled inositol phosphate production.
basal and ligand-activated conditions. In order to define the
itinerary of PLC7 molecules participating in PDGF-coupled
inositol phosphate production, we have used these tools to
follow changes in PLC7 intracellular localization, phosphoryla-
tion state, and occupancy in complexes with PDGF receptors.
Only a small fraction of the total pool of PLC7 molecules
present in BALB c/3T3 cells actually can be marked as having
interacted with PDGF receptors following PDGF stimulation.
Under conditions where fully 35% of PDGF receptors undergo
activation (as marked by tyrosine phosphorylation), only 5 to
7% of the total cellular pool of PLC7 is either tyrosine phos-
phorylated or coprecipitable with PDGF receptors 1101. Obvi-
ously, both the phosphorylation state of PLC7 molecules and
their presence in complexes with PDGF receptors may be
dynamic; steady state accumulation of tyrosine phosphorylated
or receptor association PLC7 molecules, may underrepresent
the fraction actually participating (see below).
Nevertheless, these approaches have allowed us to explore:
1) the functional importance of the coprecipitable PDGF R-PLC
complex in mediating PDGF-coupled InsP production; 2)
whether the PLC7 coprecipitating with PDGF R is tyrosine
phosphorylated; and 3) the subcellular distribution of PLC to
particulate or soluble fractions following tyrosine phosphoryla-
tion. The findings suggest the integrity of the PDGF receptor-
PLC7 complex is important in activation of PLC7.
Early experiments demonstrated that PIP2-specific PLC ac-
tivity coprecipitated with PDGF receptors from PDGF-stimu-
lated, but not unstimulated, cells [211. Coprecipitation of PLC
activity with ligand-activated PDGF receptors correlated well
over varying PDGF doses with PLC-mediated generation of
inositol phosphates. Moreover, the PLC activity coprecipitat-
ing with PDGF receptors accounted for approximately 60% of
that recovered by phosphotyrosine antibodies from PDGF
stimulated cells. Thus a significant fraction of the PLC activity
apparently participating in the PDGF-initiated response was
recoverable in a complex with activated PDGF receptors.
Several features of the interaction between PDGF Rand PLC
have provided useful experimental tools. Both PDGF-medi-
tated tyrosine phosphorylation of PLC and formation of the
coprecipitable complex with PDGF R occur at 4°C, albeit at
delayed times compared with events occuring at 37°C. Because
cellular endocytic processes are interrupted at reduced temper-
ature, the PDGF-bound surface receptors are not internalized.
Remaining on the cell surface, the PDGF bound to these
activated receptors may be effectively stripped off receptors,
after activated PDGF receptors have phosphorylated PLC7
tyrosine residues. Removal of PDGF bound at 4°C permitted us
to determine if tyrosine phosphorylation of PLC7 was sufficient
to commit subsequent inositol phosphate production upon
rewarming.
Depicted in Figure 4, the PDGF-initiated generation of InsP
from cells exposed to PDGF at 4°C proceeds effectively upon
rewarming to 37°C, as long as PDGF bound to surface receptors
was retained. When bound PDGF was stripped from surface
receptor sites before rewarming, PDGF receptor mediated InsP
production was disrupted. Characterizing the effects of acid
removal of bound PDGF, we found that the tyrosine phosphate
was initially retained in the majority of PLC7 molecules which
were phosphorylated by ligand-activated PDGF receptors at
4°C. However, the acid dissociation of bound PDGF completely
disrupted the coprecipitable PDGF receptor-PLC7 complex
[101.
Also depicted in Figure 4, disruption of the PDGF receptor-
PLC7 complexes correlated with the abrupt tyrosine dephos-
phorylation of PDGF receptors upon ligand dissociation. When
the dephosphorylation was blocked by pretreatment of the cells
with the protein tyrosine phosphatase inhibitor, orthovanadate,
both InsP production upon rewarming and the integrity of the
PDGF R-PLC7 complex were preserved. These findings may be
interpret to show that integrity of the complex containing PLC7
and PDGF receptors is functionally required at the time of
rewarming in order for InsP production to follow. This suggests
that the tyro sine phosphorylation of PLC7 which occurs at 4°C
is insufficient to promote productive PLC7 activation. Further
experiments showed that the receptor-associated PLC7 does
not contain phosphotyrosine. This is consistent with the idea
Blocked at 4° C
Proposed Requirements for PLC-mediatedDemonstrated:
InsP Production:1. PDGF binding Membrane Association2. A dimerization 1. Temperature sensitive step 01Ifl•flhJ 'Determinant'3. Kinase activation (requiring PDGF R occupancy at 370 C)
4. SeIf-phosphorylation 2. PLCg (-y-P) membrane essociation * Catalytically activated5. PLC9 association (free of PDGF A complex)
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Tyrosine phosphate7. Dissociation from PDGF R
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Fig. 5. Model of intermediate steps in PDGF receptor activation of PLC. Interruption of the PDGF R-PLC,, complex prior to temperature
transition to 37°C abrogates a step necessary for PLC activation, despite completion of PLC tyrosine phosphorylation before the transition.
that receptor-mediated tyrosine phosphorylation of PLC,, coin-
cides with dissociation of PLC,, from the receptor. Indeed,
tyrosine phosphorylation of PLC,, may be required for its
dissociation from the complex with PDGF receptors.
These findings have led us to conclude that integrity of the
receptor-PLC,, complex may be required for a completion of a
temperature-sensitive process separate from tyrosine phos-
phorylation of PLC,,. When PDGF receptor-mediated tyrosine
phosphorylation of PLC,, occurs at 4°C, it appears that some
component function required for inositol phosphate production
is not completed, as the model in Figure 5 delineates. Thus, it
appears that the stable association of PLC,, with PDGF recep-
tors serves some additional purpose beyond tyrosine phosphor-
ylation of PLC,, by receptor kinase. Some possible functions for
this association include other temperature sensitive processes
such as mobility in the membrane, serine phosphorylation,
passing PLC,, to some membrane association determinant or
internalization itself.
Data supporting a role for membrane association determi-
nants have been generated by studies addressing the distribu-
tion of tyrosine phosphorylated PLC,, to either particulate or
soluble compartments. Since the substrate for PLC, phosphati-
dylinositol phosphates, is a component of the plasma mem-
brane, it may be expected that functionally active PLC,, would
become membrane associated, potentially through the SH3
determinant common to other proteins which function in asso-
ciation with the plasma membrane. In fact, the tyrosine phos-
phorylated PLC,, subpopulation is very inefficiently segregated
to a membrane-associated pool at 4°C; two-thirds of the ty-
rosine phosphorylated PLC,, remain in the soluble fraction,
presumably inaccessible to substrate [10].
Structural analysis of the sites of PLC,, tyrosine phosphory-
lation has provided some additional insight. Three tyrosine
residues, at positions 771, 783 and 1254 are substrate sites
phosphorylated in vivo and in vitro. When individual tyrosine
residues were substituted with phenylalanine and the mutated
PLC,, molecules expressed, the Y->F783 substitution function-
ally disabled PLC,, from PDGF receptor activation [221. This
occurred despite intact in vitro phospholipase activity and
demonstration that other tyrosine residues undergo tyrosine
phosphorylation in vivo in response to PDGF receptor activa-
tion. Positioned adjacent to both SH2 and SH3 domains,
phosphorylation of Y783 may be important for targeting PLC,, to
its membrane active compartment.
Future directions
In summary, it now appears clear that common structural
motifs have been used for overlapping functions in coupling of
tyrosine kinase receptors to effector enzymes which mediate
their responses. Further definition of the distinctive properties
of these structural domains, such as the SH2 and SH3 domains,
promises to elucidate functional requirements for biochemical
and biophysical interactions with tyrosine kinases and addi-
tional regulators of their signaling function. At present, func-
tions of proteins which share SH2 and SH3 domains have
provided us with good clues that tyrosine phosphoproteins
share capacity to stably associate with the SH2 domain, appar-
ently in processes that are controlled through this stable inter-
action, such as the PDGF receptor coupling to PLC activation.
As the G-protein coupled signaling systems have taught us,
ultimate definition of the mechanisms will require reconstitution
and well defined systems in vitro.
Among the most interesting questions posed by the structural
motifs common to different signal effector enzymes coupled to
PDGF receptor is that of specificity; in other words, what
structural determinants define the capacity of a given SH2
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domain-containing protein to participate in PDGF receptor
coupled responses. Further definition of structural motifs which
collaborate with phosphotyrosine in defining protein-protein
interaction is necessary. It is clear, however, that the structural
information provided by cDNA cloning is providing a rich
opportunity for understanding these complex signaling systems.
It is hoped that future work will discriminate the distinctive
signaling systems used by differentiated cell types for special-
ized responses to ligands such as PDGF in the kidney and
elsewhere.
Reprint requests to Tom Daniel, M.D., MCN S3223, Vanderbilt
University, Nashville, Tennessee 37064, USA.
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